For speedy launch
iSTAR Medical Expands Commercial Rollout with First MINIject®Surgeries in Switzerland
-
The solely commercially accessible MIGS gadget at present focusing on the supraciliary area now accessible to sufferers and surgeons in Switzerland
-
First implantations carried out by Prof. Dr Kaweh Mansouri at Swiss Visio, Clinique de Montchoisi, Lausanne and Prof. Dr med. Jan Darius Unterlauft at Inselspital, Bern
WAVRE, Belgium — 10 May 2022: iSTAR Medical, a medtech firm delivering breakthrough eye care options to sufferers, as we speak introduced that it has continued its business rollout growth for MINIject® to Switzerland. MINIject® is iSTAR Medical’s minimally-invasive glaucoma surgical procedure (MIGS) implant and at present the one commercially accessible supraciliary MIGS gadget. Swiss sufferers with open-angle glaucoma at the moment are capable of profit from MINIject®, which has demonstrated significant and sustained efficiency, mixed with a positive security profile.
The first implants with MINIject® have now been efficiently accomplished at Swiss Visio, Clinique de Montchoisi, Lausanne by Prof. Dr Kaweh Mansouri and Inselspital, Bern by Prof. Dr med. Jan Darius Unterlauft. This follows iSTAR Medical’s current growth of MINIject® into the UK in March.
Glaucoma is the main reason for irreversible blindness, affecting round 100 million individuals worldwide and roughly 10 million in Europe alone.1,2 MIGS represents probably the most promising and fastest-growing glaucoma remedy, resulting from its enhanced security profile in comparison with conventional surgical procedure.1
Prof. Dr Kaweh Mansouri, Glaucoma Specialist (Lausanne) commented: “Glaucoma is a growing problem in the increasingly ageing Swiss population, with glaucoma incidence rising from 2% of people over the age of 50 to 5-8% in those over 70. Access to MINIject will now enable me to offer a novel and safe minimally-invasive surgical approach to my patients, deferring more invasive surgery, and preserving vision for longer.”
Prof. Dr med. Jan Darius Unterlauft (Bern) commented: “I am delighted to be able to offer MINIject to patients currently living with open–angle glaucoma. This innovative MIGS device, with its distinctive STAR material, provides a clear benefit to my patients to achieve the right balance of meaningful intraocular pressure reduction with favourable safety, sustained over the longer-term.”
Michel Vanbrabant, CEO of iSTAR Medical, commented: “Following our recent expansion in the UK, our roll out into Switzerland further realises our commitment to provide patients and surgeons across Europe access to MINIject, currently the only commercially available MIGS device targeting the supraciliary space. With the timely addition of Switzerland, we are on track in our mission to preserve the vision of glaucoma patients throughout Europe.”
– Ends –
For more information
Katherin Awad
Head of Marketing, iSTAR Medical
[email protected]; +32 10 77 16 54
For media
Consilium Strategic Communications
Amber Fennell, Chris Welsh, Kris Lam
[email protected]
About iSTAR Medical
iSTAR Medical is committed to delivering breakthrough eye care solutions. Our most advanced product, MINIject®, is approved in Europe for the treatment of open-angle glaucoma – the leading cause of irreversible blindness – and we are aiming to seek market approval in the US. We believe MINIject®’s distinctive tissue-integrating capabilities unlock a safer, and more effective option for patients. We are building an exceptional team and pipeline of potentially leading products such as MINIject® to establish new treatment paradigms in eye care conditions with the highest patient needs. For more information, please visit: www.istar-medical.com
About MINIject®
MINIject® is iSTAR Medical’s innovative MIGS device for patients with primary open-angle glaucoma. MINIject® combines the distinctive porous structure of its proprietary STAR material with the power offered by the supraciliary space. As a result, it is designed to enhance natural fluid outflow, reducing intraocular pressure (IOP) and the need for medication, while bio-integrating with surrounding tissue, limiting inflammation, fibrosis and subsequent complications.
About Glaucoma
Glaucoma is a progressive disease affecting over 100 million people globally, of which primary open-angle glaucoma is the most common form.1,2 IOP reduction, through medication or surgery, helps delay disease progression.3 Medication is generally the first line treatment, but the progressive addition of multiple drops can burden patients with side effects, compliance challenges and costs.1,3 Invasive surgery can present risks with irreversible complications and often requires long-term patient management.1,3 MIGS is the most promising and fastest-growing glaucoma therapy due to its enhanced safety profile.1 We believe MINIject® may become a leading MIGS device with its promising long-term efficacy and safety.
1 Market Scope, “2021 Glaucoma Surgical Device Market Report”, July 2021. https://www.market-scope.com/pages/reports/267/2021-glaucoma-surgical-device-market-report
2 Jonas JB, Aung T, Bourne RR et al. “Glaucoma”. Lancet 2017; 390: 2083–93
3 “European Glaucoma Society Terminology and Guidelines for Glaucoma”, 4th Edition: British Journal of Ophthalmology. 2017;101:1-195 https://bjo.bmj.com/content/101/5/73
iSTAR Medical Expands Commercial Rollout with First MINIject® Surgeries in Switzerland & More Latest News Update
iSTAR Medical Expands Commercial Rollout with First MINIject® Surgeries in Switzerland & More Live News
All this news that I have made and shared for you people, you will like it very much and in it we keep bringing topics for you people like every time so that you keep getting news information like trending topics and you It is our goal to be able to get
all kinds of news without going through us so that we can reach you the latest and best news for free so that you can move ahead further by getting the information of that news together with you. Later on, we will continue
to give information about more today world news update types of latest news through posts on our website so that you always keep moving forward in that news and whatever kind of information will be there, it will definitely be conveyed to you people.
iSTAR Medical Expands Commercial Rollout with First MINIject® Surgeries in Switzerland & More News Today
All this news that I have brought up to you or will be the most different and best news that you people are not going to get anywhere, along with the information Trending News, Breaking News, Health News, Science News, Sports News, Entertainment News, Technology News, Business News, World News of this news, you can get other types of news along with your country and city. You will be able to get information related to, as well as you will be able to get information about what is going on around you through us for free
so that you can make yourself a knowledgeable by getting complete information about your country and state and information about news. Whatever is being given through us, I have tried to bring it to you through other websites, which you may like
very much and if you like all this news, then definitely around you. Along with the people of India, keep sharing such news necessary to your loved ones, let all the news influence them and they can move forward two steps further.
Credit Goes To News Website – This Original Content Owner News Website . This Is Not My Content So If You Want To Read Original Content You Can Follow Below Links